| 2007 | | A pharmaceutical composition for the treatment of allergic diseases and chronic inflammatory diseases | 남동호 |
| 2010 | | A pharmaceutical composition for the treatment or prevention of allergic disease and autoimmune disease, use thereof, and a method for treatment or prevention of allergic disease and autoimmune disease | 남동호 |
| - | | An acidic buffer solution for manufacturing therapeutic immunoglobulin preparation, manufacturing method of therapeutic immunoglobulin preparation using the acidic buffer solution and therapeutic immunoglobulin preparation maid by this method | 남동호 |
| 2014 | | Antibiotics allergy diagnosis kit comprising antibiotics-human serum protein conjugate | 김승현, 박해심 |
| - | | Antibody Binding to human IL-5Rα and Uses Thereof | 박해심, 정근옥 |
| - | | Bispecific Antibody Binding to Human Interleukin-4 receptor alpha subunit and Interleukin-5 receptor alpha subunit and Uses Thereof | 박해심, 정근옥 |
| 2016 | | CLINICAL TRIAL DATA MANAGEMENT SYSTEM AND METHOD | 박해심, 예영민 |
| 2018 | | Composition comprising expression regulator for preventing or treating non-alcoholic fatty liver | 유민숙, 임인경, 최정아 |
| 2013 | | Composition for diagnosis of allergic rhinitis comprising agents determining lactoferrin expression level | 김승현, 박해심, 예영민, 최길순 |
| 2007 | | Composition for prevention, treatment and diagnosis ofchronic obstructive pulmonary disease | 남동호 |
| - | | Cosmetic Composition for Prevention of Skin Senescence | 김홍석, 유민숙, 임인경, 최옥란 |
| 2021 | | High Affinity Human Antibodies Against Human Interleukin-4 Receptor alpha and Uses Thereof | 박해심, 정근옥 |
| 2018 | | Immune modulator for the control of airway immune dysfunction to bacteria-derived extracellular vesicles | 박한기, 박해심, 최영우 |
| 2019 | | Increasing red muscle mass through TIS21 gene expression | 유민숙, 임인경 |
| 2019 | | Method for Diagnosing Isocyanate Occupational Asthma Using Periostin | 박해심, 이지호, 최영우 |
| 2017 | | Method for Diagnosis of Severe Asthma Using S1P and Sphingosine | 김승현, 박해심 |
| 2022 | | Methods for diagnosing of Chronic urticaria | 박해심, 최영우 |
| - | | Nanovesicles derived from Bifidobacterium bacteria and Use thereof | 박해심 |
| - | | Nanovesicles derived from Lactococcus bacteria and Use thereof | 박해심 |
| 2017 | | Pharmaceutical composition for preventing or treating miRNA-34a related diseases comprising inducer or activator of TIS21 and screening method thereof | 유민숙, 임인경 |
| - | | Pharmaceutical composition for the prevention or treatment of diseases associated with immune dysregulation comprising oxidized immunoglobulin | 남동호 |
| - | | Pharmaceutical composition for the prevention or treatment of diseases associated with immune dysregulation comprising oxidized immunoglobulin | 남동호 |
| 2012 | | Polynucleotides comprising single nucleotide polymorphism, microarrays and diagnostic kits comprising the same, and analytic methods using the same | 김승현, 박해심, 예영민 |
| 2018 | | Recombinant BTG2 protein and production method thereof | 유민숙, 임인경 |
| - | | SNP gene for diagnosis of aspirin-induced asthma | 김승현, 박해심, 예영민 |
| - | | SNP gene set for diagnosis of aspirin-induced urticaria | 김승현, 박해심, 예영민 |
